We explored patient subgroups to determine if PTK7 expression was associated with breast cancer-specific survival and determined that protein and mRNA expression were associated with survival of poor prognostic NPI groups and moderate prognostic NPI groups, respectively. Here, PTK7 is linked to breast carcinoma.